Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers[J]. Protein&Cell, 2019, 10(12): 927-928. doi: 10.1007/s13238-019-0640-1
|
Citation:
|
Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers[J]. Protein&Cell, 2019, 10(12): 927-928. doi: 10.1007/s13238-019-0640-1
|
Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers[J]. Protein&Cell, 2019, 10(12): 927-928. doi: 10.1007/s13238-019-0640-1
|
Citation:
|
Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers[J]. Protein&Cell, 2019, 10(12): 927-928. doi: 10.1007/s13238-019-0640-1
|
DownLoad: